Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating access restrictions rather than new or updated study details. The header and footer remain visible, but no study information is presented.SummaryDifference19%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a new Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page or site infrastructure.SummaryDifference0.1%

- Check52 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5, indicating a deployment update. The change does not modify the displayed study information.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.4, updating the deployment tag from v3.6.3. This signals a frontend release and does not modify the study text or results.SummaryDifference0.1%

- Check88 days agoChange DetectedThe study record's revision tag changed from v3.6.2 to v3.6.3, indicating a minor update to the documentation. No substantive content of the study record was modified.SummaryDifference0.1%

- Check95 days agoChange DetectedThe study record now shows Terminated with a note about COVID-19–related enrollment halts, reflecting the current state of the trial; the previous Completed status and older revision tag have been superseded by this update.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.